Mucormycosis and Diabetes Mellitus

被引:0
作者
Ditu, Georgiana [1 ]
Voiculescu, Daniela Caliopi [1 ]
Bodnarescu, Mihaela [1 ]
Pantea Stoian, Anca [2 ]
Hainarosie, Razvan [2 ,3 ]
Stefan, Simona [1 ,2 ]
Serafinceanu, Cristian [1 ,2 ]
机构
[1] Natl Inst Diabet Nutr & Metab Dis NC Paulescu, Bucharest, Romania
[2] Univ Med & Pharm Carol Davila, Bucharest, Romania
[3] Prof Dr Dorin Hociota Inst Phonoaudiol & Funct EN, 21st Mihail Cioranu St, Bucharest, Romania
来源
PROCEEDINGS OF NATIONAL ENT, HEAD AND NECK SURGERY CONFERENCE | 2018年
关键词
diabetes mellitus; mucormycosis; fungal infections; ZYGOMYCOSIS;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Introduction Mucormycosis is a rare, potentially fatal, invasive fungal infection that occurs mainly in immunocompromised patients (malignant haematological pathologies, organ transplantation, AIDS, severe neutropenia) and unbalanced diabetes with rapid progression. A feature of this fungus is an invasion of the blood vessels causing thrombosis and subsequently necrosis. Clinical polymorphic manifestations often delay diagnosis and can lead to a poor outcome. A high degree of suspicion for mucormycosis in patients with risk factors is required, and an adequate risk stratification with improved laboratory diagnosis in specialised centres is essential for improving the prognosis of this devastating disease. Material and methods We reviewed the literature by searching the MEDLINE database for the most representative articles published so far. The studies that we selected were observational studies and raised the hypothesis of a link between diabetes mellitus and mucormycosis. Conclusions The purpose of this review was to draw attention to this pathology, to recognise it when we see it in clinical practice in patients with diabetes and to take the necessary therapeutic decisions as soon as possible to save the patient's life.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 24 条
  • [1] [Anonymous], J ANTIMICROB CHEMOTH
  • [2] A MECHANISM OF SUSCEPTIBILITY TO MUCORMYCOSIS IN DIABETIC-KETOACIDOSIS - TRANSFERRIN AND IRON AVAILABILITY
    ARTIS, WM
    FOUNTAIN, JA
    DELCHER, HK
    JONES, HE
    [J]. DIABETES, 1982, 31 (12) : 1109 - 1114
  • [3] Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes
    Bhansali, A
    Bhadada, S
    Sharma, A
    Suresh, V
    Gupta, A
    Singh, P
    Chakarbarti, A
    Dash, RJ
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2004, 80 (949) : 670 - 674
  • [4] DEFEROXAMINE THERAPY AND MUCORMYCOSIS IN DIALYSIS PATIENTS - REPORT OF AN INTERNATIONAL REGISTRY
    BOELAERT, JR
    FENVES, AZ
    COBURN, JW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (06) : 660 - 667
  • [5] Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole
    Chamilos, G
    Lewis, RE
    Kontoyiannis, DP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 96 - 103
  • [6] DALY AL, 1989, AM J MED, V87, P468, DOI 10.1016/S0002-9343(89)80836-8
  • [7] GALE GR, 1961, AM J MED SCI, V241, P604
  • [8] Zygomycosis (mucormycosis): emerging clinical importance and new treatments
    Greenberg, RN
    Scott, LJ
    Vaughn, HH
    Ribes, JA
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) : 517 - 525
  • [9] Primary care: Infections in patients with diabetes mellitus
    Joshi, N
    Caputo, GM
    Weitekamp, MR
    Karchmer, AW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (25) : 1906 - 1912
  • [10] Decrease in the number of reported cases of zygomycosis among patients with diabetes mellitus: A hypothesis
    Kontoyiannis, Dimitrios P.
    [J]. CLINICAL INFECTIOUS DISEASES, 2007, 44 (08) : 1089 - 1090